Literature DB >> 9419059

Assessment of depression in patients with motor neuron disease and other neurologically disabling illness.

B M Tedman1, C A Young, I R Williams.   

Abstract

Motor neuron disease (MND) is a severely disabling, relentlessly progressive neurological condition with a marked reduction in life expectancy which might be expected to be associated with significant depression and psychological dysfunction following diagnosis. There is very little data on the incidence of depression in MND and most of the published evidence would suggest that depression is rare in patients with MND, especially when compared to other neurologically disabling illnesses. We have studied 40 patients with MND and compared them to a group of 92 patients with multiple sclerosis (MS) attending a neurology clinic. Depression was assessed using the Beck Depression Index (BDI) and the Hospital Anxiety and Depression Scale (HAD). There was no difference in incidence or severity of depression in these two patient groups. For the whole study group there was no difference in depression scores when compared by age, gender or marital status. Depression scores showed a weak association with increasing physical disability measured by the SF36 Physical Function scale for the MS group but there was no association between depression levels and SF36 physical function for the MND group. The MND group did, however, show a significant association between depression scores and pain measured by the SF36 scale. Anxiety levels (HAD scale) were shown to be significantly higher in females and married (versus single, widowed or divorced) subjects for the group as a whole. We conclude that depression is at least as common in MND patients as other neurologically disabled patients with MS and may often be associated with significant pain. Physicians and others involved in the care of patients with MND should be aware that depression and pain may be significant problems irrespective of the level of physical disability.

Entities:  

Mesh:

Year:  1997        PMID: 9419059     DOI: 10.1016/s0022-510x(97)00249-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Assessing individual quality of life in amyotrophic lateral sclerosis.

Authors:  S Clarke; A Hickey; C O'Boyle; O Hardiman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Depression in amyotrophic lateral sclerosis.

Authors:  Nazem Atassi; Amanda Cook; Cristiana M E Pineda; Padmaja Yerramilli-Rao; Darlene Pulley; Merit Cudkowicz
Journal:  Amyotroph Lateral Scler       Date:  2010-11-24

3.  Prevalence of depressive disorders and change over time in late-stage ALS.

Authors:  J G Rabkin; S M Albert; M L Del Bene; I O'Sullivan; T Tider; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

Review 4.  Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Johannes Brettschneider; Jerome Kurent; Albert Ludolph
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 5.  Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management.

Authors:  Anja Kurt; Femke Nijboer; Tamara Matuz; Andrea Kübler
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS).

Authors:  Sabrina Paganoni; Erin McDonnell; David Schoenfeld; Hong Yu; Jing Deng; Hamza Atassi; Alexander Sherman; Padmaja Yerramilli-Rao; Merit Cudkowicz; Nazem Atassi
Journal:  J Neurol Neurophysiol       Date:  2017-04-29

7.  Low depressive symptoms in acute spinal cord injury compared to other neurological disorders.

Authors:  Katayun Hassanpour; Sabina Hotz-Boendermaker; Petra Dokladal; Armin Curt
Journal:  J Neurol       Date:  2011-11-18       Impact factor: 4.849

8.  A pilot study of the prevalence of psychiatric disorders in PLS and ALS.

Authors:  Edward D Huey; Jeremy Koppel; Nicole Armstrong; Jordan Grafman; Mary Kay Floeter
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

Review 9.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

10.  Depression and quality of life issues in patients with amyotrophic lateral sclerosis.

Authors:  Shannon F Stromberg; David B Weiss
Journal:  Curr Treat Options Neurol       Date:  2006-09       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.